CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Rein Therapeutics Inc - ALRN CFD

2.0232
3.8%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0236
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023346 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001124 %
Charges from full value of position ($0.21)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001124%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.01
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 2.1032
Open 1.9432
1-Year Change -56.19%
Day's Range 1.9432 - 2.0232
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 17, 2025 2.0232 0.0200 1.00% 2.0032 2.0232 1.9432
Jan 10, 2025 2.1032 0.2100 11.09% 1.8932 2.1332 1.8932
Jan 8, 2025 1.9232 -0.0900 -4.47% 2.0132 2.0732 1.8532
Jan 7, 2025 2.0332 -0.0200 -0.97% 2.0532 2.0932 2.0332
Jan 6, 2025 2.0732 -0.1500 -6.75% 2.2232 2.2232 2.0432
Jan 3, 2025 2.2532 0.0400 1.81% 2.2132 2.2832 2.0532
Jan 2, 2025 2.2432 -0.0400 -1.75% 2.2832 2.3432 2.1932
Dec 31, 2024 2.2832 0.0600 2.70% 2.2232 2.3232 2.2232
Dec 30, 2024 2.2932 0.1000 4.56% 2.1932 2.3132 2.1632
Dec 27, 2024 2.2032 0.0200 0.92% 2.1832 2.2632 2.1032
Dec 26, 2024 2.2232 0.0200 0.91% 2.2032 2.2632 2.0032
Dec 24, 2024 2.1532 0.2600 13.73% 1.8932 2.2332 1.8932
Dec 23, 2024 1.8632 0.1400 8.12% 1.7232 1.8932 1.6532
Dec 20, 2024 1.7432 -0.0600 -3.33% 1.8032 1.8332 1.7232
Dec 19, 2024 1.7432 -0.1000 -5.43% 1.8432 1.8732 1.7332
Dec 18, 2024 1.8532 -0.2500 -11.89% 2.1032 2.1032 1.8232
Dec 17, 2024 1.9132 -0.1900 -9.03% 2.1032 2.1432 1.8432
Dec 16, 2024 2.1132 -0.0600 -2.76% 2.1732 2.3032 2.0432
Dec 13, 2024 2.2532 0.2400 11.92% 2.0132 2.3832 1.8632
Dec 12, 2024 2.0032 -0.1900 -8.66% 2.1932 2.1932 1.9032

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Aileron Therapeutics, Inc. Company profile

About Aileron Therapeutics Inc

Aileron Therapeutics, Inc. is a clinical-stage chemoprotection oncology company. The Company is focused on transforming the experience of chemotherapy for cancer patients. It is developing ALRN-6924, which is their dual Mouse double minute 2 homolog (MDM2) and MDMX inhibitor to provide a single medicine to protect multiple healthy cell types throughout the body from chemotherapy while ensuring chemotherapy continues to destroy cancer cells. ALRN-6924 acts as an agent to reduce the toxic side effects of chemotherapy in the bone marrow of cancer patients without adversely impacting the anti-cancer activity of chemotherapy against p53-mutant tumors.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Aileron Therapeutics Inc revenues was not reported. Net loss increased 20% to $19.4M. Higher net loss reflects Research and development increase of 38% to $12.1M (expense), Stock-based Compensation in SGA increase of 20% to $1.3M (expense), General and administrative increase of 1% to $6.1M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.51 to -$0.22.

Industry: Bio Therapeutic Drugs

285 Summer Street
Unit 101
BOSTON
MASSACHUSETTS 02210
US

People also watch

BTC/USD

104,252.25 Price
+4.290% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

US100

21,441.70 Price
+1.820% 1D Chg, %
Long position overnight fee -0.0233%
Short position overnight fee 0.0011%
Overnight fee time 22:00 (UTC)
Spread 7.0

ETH/USD

3,435.27 Price
+3.830% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Gold

2,703.08 Price
-0.430% 1D Chg, %
Long position overnight fee 0.0056%
Short position overnight fee -0.0138%
Overnight fee time 22:00 (UTC)
Spread 0.60

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading